Dimensional Fund Advisors
LFCR icon

Dimensional Fund Advisors’s Lifecore Biomedical LFCR Stock Holding History

Dimensional Fund Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-38,897
Closed -$147K – 3500
2023
Q1 		$147K Sell
38,897
-1,718,647
-98% -$9.58M ﹤0.01% 3255
2022
Q4 		$11.4K Sell
1,757,544
-76,358
-4% -$629K ﹤0.01% 2141
2022
Q3 		$16.3M Sell
1,833,902
-97,706
-5% -$994K 0.01% 1930
2022
Q2 		$19.3M Sell
1,931,608
-39,474
-2% -$391K 0.01% 1884
2022
Q1 		$22.8M Sell
1,971,082
-2,526
-0.1% -$28.1K 0.01% 1897
2021
Q4 		$21.9M Sell
1,973,608
-59,162
-3% -$574K 0.01% 1934
2021
Q3 		$18.7M Sell
2,032,770
-37,223
-2% -$405K 0.01% 2035
2021
Q2 		$23.3M Sell
2,069,993
-66,487
-3% -$766K 0.01% 1982
2021
Q1 		$22.7M Sell
2,136,480
-82,881
-4% -$932K 0.01% 1973
2020
Q4 		$24.1M Sell
2,219,361
-77,860
-3% -$804K 0.01% 1885
2020
Q3 		$22.3M Sell
2,297,221
-44,162
-2% -$421K 0.01% 1788
2020
Q2 		$18.6M Sell
2,341,383
-107,328
-4% -$1.11M 0.01% 1912
2020
Q1 		$21.3M Buy
2,448,711
+17,178
+0.7% +$179K 0.01% 1705
2019
Q4 		$27.5M Buy
2,431,533
+2,375
+0.1% +$25.3K 0.01% 1868
2019
Q3 		$26.4M Buy
2,429,158
+23,333
+1% +$254K 0.01% 1853
2019
Q2 		$22.5M Buy
2,405,825
+44,768
+2% +$452K 0.01% 1980
2019
Q1 		$29M Buy
2,361,057
+29,401
+1% +$359K 0.01% 1849
2018
Q4 		$27.6M Sell
2,331,656
-523
-0% -$7.18K 0.01% 1797
2018
Q3 		$33.6M Buy
2,332,179
+17,353
+0.7% +$240K 0.01% 1816
2018
Q2 		$34.5M Sell
2,314,826
-14,314
-0.6% -$199K 0.01% 1769
2018
Q1 		$30.4M Buy
2,329,140
+5,151
+0.2% +$67.7K 0.01% 1804
2017
Q4 		$29.3M Buy
2,323,989
+13,245
+0.6% +$167K 0.01% 1848
2017
Q3 		$29.9M Buy
2,310,744
+13,077
+0.6% +$172K 0.01% 1793
2017
Q2 		$34.1M Buy
2,297,667
+7,276
+0.3% +$101K 0.02% 1634
2017
Q1 		$27.5M Sell
2,290,391
-249
-0% -$3.15K 0.01% 1780
2016
Q4 		$31.6M Buy
2,290,640
+37,124
+2% +$514K 0.02% 1599
2016
Q3 		$30.2M Buy
2,253,516
+5,417
+0.2% +$65.6K 0.02% 1569
2016
Q2 		$24.2M Sell
2,248,099
-48,150
-2% -$531K 0.01% 1683
2016
Q1 		$24.1M Buy
2,296,249
+2,700
+0.1% +$29.7K 0.01% 1660
2015
Q4 		$27.1M Buy
2,293,549
+3,621
+0.2% +$44.5K 0.02% 1497
2015
Q3 		$26.7M Buy
2,289,928
+17,280
+0.8% +$229K 0.02% 1458
2015
Q2 		$32.8M Buy
2,272,648
+55,360
+2% +$799K 0.02% 1336
2015
Q1 		$30.9M Buy
2,217,288
+37,977
+2% +$525K 0.02% 1356
2014
Q4 		$30.1M Buy
2,179,311
+28,416
+1% +$367K 0.02% 1306
2014
Q3 		$26.3M Buy
2,150,895
+23,517
+1% +$294K 0.02% 1320
2014
Q2 		$26.6M Buy
2,127,378
+30,605
+1% +$360K 0.02% 1338
2014
Q1 		$23.4M Sell
2,096,773
-10,614
-0.5% -$116K 0.02% 1413
2013
Q4 		$25.5M Sell
2,107,387
-33,084
-2% -$395K 0.02% 1266
2013
Q3 		$26.1M Buy
2,140,471
+5,219
+0.2% +$72.8K 0.02% 1096
2013
Q2 		$28.2M Buy
+2,135,252
New +$29.5M 0.03% 907

Other funds holding LFCR

GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Dimensional Fund Advisors's LFCR Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of Lifecore Biomedical (LFCR) in Q2 2023, closing a stake of 38,897 shares — an estimated $147K sold.

Dimensional Fund Advisors first reported a position in LFCR in Q2 2013 and held it in 40 quarters. The position peaked at $34.5M in Q2 2018. 75 funds tracked by Wall St. Rank hold LFCR as of Q2 2023.

  • Dimensional Fund Advisors reported no remaining Lifecore Biomedical position as of Q2 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 38,897 Lifecore Biomedical shares in Q2 2023, an estimated $147K.
  • Dimensional Fund Advisors first reported a position in Lifecore Biomedical in Q2 2013 and held it in 40 quarters.
  • Dimensional Fund Advisors's Lifecore Biomedical position peaked at $34.5M in Q2 2018.
  • 75 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.